Sign In
This Site: Home
Lillyoncology
Advanced Search
Home
Home
Lilly Oncology Site Map
Lilly Oncology Home
Lilly Oncology Products
ALIMTA
®
(pemetrexed for injection)
1st-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (Not Indicated for Squamous Cell NSCLC)
Trial Design
Efficacy
Histologic Efficacy
Safety
Dosing
Maintenance Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (Not Indicated for Squamous Cell NSCLC)
Trial Design
Efficacy
Histologic Efficacy
Safety
Dosing
2nd-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (Not Indicated for Squamous Cell NSCLC)
Trial Design
Efficacy
Safety
Dosing
Treatment for Malignant Pleural Mesothelioma
Trial Design
Efficacy
Safety
Dosing
Tools and Resources
Resources for Healthcare Professionals
Patient Support
Indications and Important Safety Information for ALIMTA
GEMZAR
®
(gemcitabine HCl for injection)
Ovarian Cancer
Trial Design
Efficacy
Safety
Dosing
Non-Small Cell Lung Cancer
Trial Design
Efficacy
Safety
Dosing
Metastatic Breast Cancer
Trial Design
Efficacy
Safety
Dosing
Pancreatic Cancer
Trial Design
Efficacy
Safety
Dosing
Tools and Resources
Healthcare Professional Resources
Interactive Treatment Tools
Patient Support
Indications and Important Safety Information for GEMZAR
Patient Education and Support
Staging Galleries
Virtual Lung Cancer Staging Gallery
Ovarian Cancer Staging Gallery
Friends & Caregivers
Online Patient Resources
Lilly Oncology Programs
PatientOne
Lilly Oncology On Canvas
Privacy Statement
Copyright
Terms of Use
Contact Us